Loading company…
Neurosoft Bioelectronics develops soft brain-computer interfaces for neural tissue.
Neurosoft Bioelectronics develops soft, elastic brain-computer interfaces intended to improve integration with neural tissue and reduce scarring. It targets healthcare providers and research institutions. Founded in 2020 in Geneva, Switzerland, the company raised USD 7.5 mn in Seed funding in May 2026, led by Skybound Venture Capital, with Connecticut Innovations, IAG Capital Partners and Protocol Labs, Inc. participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in